EMA
approval
· 2023-05-25
EMA Authorised: Pantozol Control (pantoprazole) — Takeda GmbH
Summary
Authorisation of Pantozol Control (pantoprazole) by EMA for gastroesophageal reflux disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Gastroesophageal Reflux. MAH: Takeda GmbH. Decision date: 26/04/2023